Pilot Study of a Decision Aid Intervention for Family-building After Cancer
This study tests a web-based decision aid and planning too to help young female cancer survivors manage fertility and family-building issues in post treatment survivorship.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- behavioral: Web based decision aid intervention
Eligibility
Inclusion Criteria:
- Female
- Completed cancer treatment known to have gonadotoxic effects (e.g., systemic
chemotherapy, surgery affecting reproductive organs or hormone regulation, and/or
pelvic radiation)
- Understands verbal and written English
- Desires future children or uncertainty regarding family-building plans
- Access to the Internet and use of a computer, tablet, or smartphone
Exclusion Criteria:
- Currently undergoing cancer treatment excluding long-term adjuvant or maintenance
therapies, such as tamoxifen
- Significant physical or mental disability that prevents completion of study activities
Note: Survivors on adjuvant maintenance or endocrine treatment, such as tamoxifen, will not
be excluded because clinical guidelines allow treatment delay or hiatus to accommodate
fertility preservation, egg extraction for surrogacy, or pregnancy for some patients, and
because patients may be interested in alternative family-building options such as surrogacy
or adopting.
Ages Eligible for Study
18 Years - 45 Years
Genders Eligible for Study
Female
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Catherine Benedict
650-736-7659
Not Recruiting
Our research team includes physicians, residents, medical students, research assistants, and volunteers. Our research topics include medical imaging, device validation, mobile application development, and pharmaceutical trials.
Some of the Neuro-Opthalmic concerns we investigate include Multiple Sclerosis, Optic Neuritis, IIH, and ICP.
